Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Low-dose oral minoxidil can cause serious side effects like heart issues, so use the lowest effective dose.

Minoxidil may help treat hair loss by reducing the activity of a specific enzyme linked to baldness.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Both treatment combinations improved hair growth similarly and were safe.

Targeting the RAAS with small molecules can improve cardiovascular disease treatments.

Minoxidil can cause heart inflammation, so users should be monitored.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Minoxidil can make it hard to detect cocaine in hair tests.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Low-dose oral minoxidil can cause serious heart complications.

Using both 5% spironolactone and 5% minoxidil together is safe and more effective for treating hair loss.

Nanocarriers with spironolactone and 2-deoxy-D-ribose may improve hair loss treatment by targeting hair follicles directly.

Minoxidil protects brain tissue directly, not by lowering blood pressure.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Anti-androgens can help reduce the effects of male hormones on the skin.

Minoxidil can cause pericardial and pleural effusions with high protein content.

Clascoterone cream could be used for other skin conditions affected by hormones.

Minoxidil lowers blood pressure and increases heart efficiency, but may raise lung artery pressure in some people.

Vasodilators may worsen abdominal aortic aneurysm.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Minoxidil and spironolactone improve hair density and reduce shedding in girls.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Astressin-B can reverse and prevent hair loss in stressed mice.

Minoxidil helps hair growth by improving blood vessel function.